Nucleic acid sequence-based amplification assays for detection of human cytomegalovirus (HCMV) immediate-early and pp67 mRNA in 65 amniotic fluid samples tested for prenatal diagnosis of congenital HCMV infection showed sensitivity, specificity, and negative and positive predictive values >90%.Prenatal diagnosis of congenital human cytomegalovirus (HCMV) infection is mostly performed by rapid virus isolation from, and/or PCR detection of viral DNA in, amniotic fluid (AF) samples (1,3,11,12,14). In general, both techniques have been shown to provide high specificity (96 to 100%) and good sensitivity (70 to 90%) (4,8,10,14,15), with the exception of a few reports from a single group showing low specificity and positive predictive value for PCR on AF samples (5, 9). Since irrevocable decisions are often made on the basis of prenatal diagnosis, the use of a confirmatory assay is highly recommended. Thus, given the lack of cell culture facilities in many laboratories, molecular assays which may confirm PCR results for AF samples, thereby functioning as alternatives to HCMV isolation, must be identified.There are two commercially available assays for detection of HCMV immediate-early (IE) and late pp67 mRNA using the nucleic acid sequence-based amplification (NASBA) technique (BioMérieux, Boxtel, The Netherlands). The assay for pp67 mRNA is available as a complete kit (NucliSens CMV pp67), whereas a basic kit (NucliSens Basic Kit) is available for IE mRNA detection; IE mRNA-specific primer sequences can be obtained from BioMérieux. Currently, the NucliSens CMV pp67 assay is approved by the Food and Drug Administration for mRNA detection in blood, while the IE mRNA NASBA basic kit is to be used for research purposes.Overall, 65 AF samples from as many pregnant women with primary HCMV infection during pregnancy were tested. Primary infection was diagnosed by either HCMV-specific immunoglobulin G (IgG) seroconversion or the presence of HCMVspecific IgM associated with a low IgG avidity index (15). The virologic outcome of pregnancy was ascertained in newborns by HCMV isolation within the first 2 weeks of life and in aborted fetuses by virus isolation from and histologic examination of fetal tissues. All AF samples had been previously characterized for HCMV presence by both rapid virus isolation on shell vial cultures and viral DNA amplification by PCR (16).NASBA assays were performed retrospectively on AF samples according to the instructions given by the manufacturer for pp67 mRNA detection in blood samples (NucliSens CMV pp67). In particular, 49 AF samples collected from September 1991 through December 1999 and stored undiluted at Ϫ80°C were diluted 1:10 in NucliSens lysis buffer (BioMérieux) upon thawing. These samples were tested by NASBA for U1A mRNA, the transcript of a cellular gene with a low rate of transcriptional activity, to verify whether RNA was degraded during storage (7). The remaining 16 samples, collected after January 2000, were stored at Ϫ80°C as 1:10 dilutions in lysis buffer. Nucleic acids were extr...